Buscar
Mostrando ítems 11-20 de 10540
SARS-CoV-2’s Variants of Concern: A Brief Characterization
(Frontiers Media, 2023)
Viral Loads of SARS-CoV-2 in Young Children
(American Medical Association, 2022)
Emergencia de SARS-CoV-2. Aspectos básicos sobre su origen, epidemiología, estructura y patogenia para clínicos
(Elsevier, 2021)
SARS-CoV-2 is the third coronavirus emerging in the last two decades producing a disease denominated COVID-19 (infectious disease by coronavirus 2019). It has demostrated to be easily transmisible between humans with a ...
SARS-CoV-2 testing, prevalence, and predictors of covid-19 in patients with inflammatory bowel disease in Northern California
Coronavirus disease 2019 (COVID-19), caused by the novel betacoronavirus SARSCoV-2, is an unprecedented global pandemic[1]. Susceptibility to COVID-19 is a concern among
patients with inflammatory bowel disease (IBD) who ...
Evolution of genomes, host shifts and the geographic spread of SARS-CoV and related coronaviruses
(Wiley Blackwell Publishing, Inc, 2008-04)
Severe acute respiratory syndrome (SARS) is a novel human illness caused by a previously unrecognized coronavirus (CoV) termed SARS-CoV. There are conflicting reports on the animal reservoir of SARS-CoV. Many of the groups ...
Structural basis of receptor recognition by SARS-CoV-2
A novel severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2)
recently emerged and is rapidly spreading in humans, causing COVID-191,2
. A key to
tackling this pandemic is to understand the receptor ...
Approaches and challenges in SARS-CoV-2 vaccine development
The explosive spread of SARS-CoV-2 suggests that a vaccine will be required to end this global pandemic.
Progress in SARS-CoV-2 vaccine development to date has been faster than for any other pathogen in history.
Multiple ...
Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV
Background: Knowledge of the COVID-19 epidemic extent and the level of herd immunity is urgently needed to
help manage this pandemic.
Methods: We used a panel of 167 samples (77 pre-epidemic and 90 COVID-19 seroconverters) ...